Terms: = Lymphoma AND TNFRSF17, BCMA, 608, ENSG00000048462, CD269, Q02223, BCM AND Diagnosis
15 results:
1. Machine Learning-Based Survival Prediction Models for Progression-Free and Overall Survival in Advanced-Stage Hodgkin lymphoma.
Rask Kragh Jørgensen R; Bergström F; Eloranta S; Tang Severinsen M; Bjøro Smeland K; Fosså A; Haaber Christensen J; Hutchings M; Bo Dahl-Sørensen R; Kamper P; Glimelius I; E Smedby K; K Parsons S; Mae Rodday A; J Maurer M; M Evens A; C El-Galaly T; Hjort Jakobsen L
JCO Clin Cancer Inform; 2024 Apr; 8():e2300255. PubMed ID: 38608215
[TBL] [Abstract] [Full Text] [Related]
2. Long non-coding RNA as a novel biomarker and therapeutic target in aggressive B-cell non-Hodgkin lymphoma: A systematic review.
Khanmohammadi S; Fallahtafti P
J Cell Mol Med; 2023 Jul; 27(14):1928-1946. PubMed ID: 37246627
[TBL] [Abstract] [Full Text] [Related]
3. The role of soluble B cell maturation antigen as a biomarker in multiple myeloma.
Alomari M; Kunacheewa C; Manasanch EE
Leuk Lymphoma; 2023 Feb; 64(2):261-272. PubMed ID: 36282671
[TBL] [Abstract] [Full Text] [Related]
4. Proteomic Landscape of Extracellular Vesicles for Diffuse Large B-Cell lymphoma Subtyping.
Carvalho AS; Baeta H; Henriques AFA; Ejtehadifar M; Tranfield EM; Sousa AL; Farinho A; Silva BC; Cabeçadas J; Gameiro P; Silva MGD; Beck HC; Matthiesen R
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681663
[TBL] [Abstract] [Full Text] [Related]
5. [Clinical Significance of Tfh/Tfr Cell Imbalance in Patients with B-Cell lymphoma].
Zheng J; Zhang Z; Chen YH; Xiao Y; Shen R; Wang L; Zhang P; Yang QY; Feng C; Gao KB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Oct; 29(5):1510-1516. PubMed ID: 34627432
[TBL] [Abstract] [Full Text] [Related]
6. Case report: simultaneous occurrence of multiple myeloma and non-Hodgkin lymphoma treated by CAR T therapy.
Li T; Tan J; Chen L; Kuang D; Mao X; Lou Y; Zhou J; Zhou X
Medicine (Baltimore); 2020 Apr; 99(16):e19739. PubMed ID: 32311967
[TBL] [Abstract] [Full Text] [Related]
7. Clinical applicability of proposed algorithm for identifying individuals at risk for hereditary hematologic malignancies.
Clifford M; Bannon S; Bednar EM; Czerwinski J; Davis J; Dunnington L; Shahrukh Hashmi S; DiNardo CD
Leuk Lymphoma; 2019 Dec; 60(12):3020-3027. PubMed ID: 31274040
[TBL] [Abstract] [Full Text] [Related]
8. Single-Cell Lymphocyte Heterogeneity in Advanced Cutaneous T-cell lymphoma Skin Tumors.
Gaydosik AM; Tabib T; Geskin LJ; Bayan CA; Conway JF; Lafyatis R; Fuschiotti P
Clin Cancer Res; 2019 Jul; 25(14):4443-4454. PubMed ID: 31010835
[TBL] [Abstract] [Full Text] [Related]
9. Effect of Conditioning Regimen Dose Reduction in Obese Patients Undergoing Autologous Hematopoietic Cell Transplantation.
Brunstein CG; Pasquini MC; Kim S; Fei M; Adekola K; Ahmed I; Aljurf M; Agrawal V; Auletta JJ; Battiwalla M; Bejanyan N; Bubalo J; Cerny J; Chee L; Ciurea SO; Freytes C; Gadalla SM; Gale RP; Ganguly S; Hashmi SK; Hematti P; Hildebrandt G; Holmberg LA; Lahoud OB; Landau H; Lazarus HM; de Lima M; Mathews V; Maziarz R; Nishihori T; Norkin M; Olsson R; Reshef R; Rotz S; Savani B; Schouten HC; Seo S; Wirk BM; Yared J; Mineishi S; Rogosheske J; Perales MA
Biol Blood Marrow Transplant; 2019 Mar; 25(3):480-487. PubMed ID: 30423481
[TBL] [Abstract] [Full Text] [Related]
10. A Comparative Analysis of Survival and Funding Discrepancies in Cancers With High Mortality.
Hall BR; Cannon A; Atri P; Wichman CS; Smith LM; Kumar S; Batra SK; Wang H; Ganti AK; Sasson AR; Are C
Ann Surg; 2020 Feb; 271(2):296-302. PubMed ID: 30188400
[TBL] [Abstract] [Full Text] [Related]
11. Soluble TACI and soluble bcma as biomarkers in primary central nervous system lymphoma.
Thaler FS; Laurent SA; Huber M; Mulazzani M; Dreyling M; Ködel U; Kümpfel T; Straube A; Meinl E; von Baumgarten L
Neuro Oncol; 2017 Nov; 19(12):1618-1627. PubMed ID: 28521029
[TBL] [Abstract] [Full Text] [Related]
12. Ki-67 is a strong predictor of central nervous system relapse in patients with mantle cell lymphoma (MCL).
Chihara D; Asano N; Ohmachi K; Nishikori M; Okamoto M; Sawa M; Sakai R; Okoshi Y; Tsukamoto N; Yakushijin Y; Nakamura S; Kinoshita T; Ogura M; Suzuki R
Ann Oncol; 2015 May; 26(5):966-973. PubMed ID: 25712457
[TBL] [Abstract] [Full Text] [Related]
13. Incidence and localization of abnormal mucosa findings in patients consulting ENT outpatient clinics and data analysis of a cancer registry.
Löhler J; Gerstner AO; Bootz F; Walther LE
Eur Arch Otorhinolaryngol; 2014 May; 271(5):1289-97. PubMed ID: 24114062
[TBL] [Abstract] [Full Text] [Related]
14. Raised expression of APRIL in Chinese children with acute lymphoblastic leukemia and its clinical implications.
Sun B; Wu Y; Wu L; Cui M; Ni H; Yang Z; Xu M; Wang H
J Pediatr Hematol Oncol; 2014 May; 36(4):276-80. PubMed ID: 23887020
[TBL] [Abstract] [Full Text] [Related]
15. The pathology of non-Hodgkin's lymphoma of childhood: II. Reproducibility and relevance of the histologic classification of "undifferentiated" lymphomas (Burkitt's versus non-Burkitt's).
Wilson JF; Kjeldsberg CR; Sposto R; Jenkin RD; Chilcote RR; Coccia P; Exelby RR; Kersey J; Meadows A; Siegel S
Hum Pathol; 1987 Oct; 18(10):1008-14. PubMed ID: 3653876
[TBL] [Abstract] [Full Text] [Related]
